The role of serine/threonine protein phosphatase type 5 (PP5) in the regulation of stress-induced signaling networks and cancer

Cancer and Metastasis Reviews

Volumn 27, Issue 2, 2008, Pages 169-178

  Golden, Teresa ^a   Swingle, Mark ^b   Honkanen, Richard E ^b  

^a SOUTHEASTERN OKLAHOMA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTH ALABAMA   (United States)

Author keywords

Cancer; Oxidative stress; Phosphatase; PP5

Indexed keywords

GLUCOCORTICOID RECEPTOR; HEAT SHOCK PROTEIN 90; HORMONE; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN P53; PROTEIN PHOSPHATASE 5; RAC PROTEIN; RAF PROTEIN; RAS PROTEIN; SERINE PROTEINASE; THREONINE PROTEINASE; TUMOR SUPPRESSOR PROTEIN;

CARCINOGENESIS; CELL GROWTH; DRUG DESIGN; GENOME; HUMAN; NEOPLASM; NONHUMAN; OXIDATIVE STRESS; PATHOLOGY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TUMOR PROMOTION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; NEOPLASMS; NUCLEAR PROTEINS; PHOSPHOPROTEIN PHOSPHATASES; PROTEIN STRUCTURE, QUATERNARY; SIGNAL TRANSDUCTION; STRESS;

EID: 43049097815     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-008-9125-z     Document Type: Review

References (75)

1. Roberts, P. J., & Der, C. J. (2007). Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene, 26, 3291-3310.
2. Milano, A., De Rosa, V., Iaffaioli, R. V., & Caponigro, F. (2007). Downstream intracellular effectors of epidermal growth factor receptor as targets for anticancer therapy. Expert Opinion on Therapeutic Targets, 11, 771-782.
3. Schmitt, E., Paquet, C., Beauchemin, M., & Bertrand, R. (2007). DNA-damage response network at the crossroads of cell-cycle checkpoints, cellular senescence and apoptosis. Journal of Zhejiang University Science B, 8(6), 377-397.
4. Shenolikar, S., & Nairn, A. C. (1991). Protein phosphatases: Recent progress. Advances in Second Messenger and Phosphoprotein Research, 23, 1-119.
5. Klumpp, S., & Krieglstein, J. (2002). Serine/threonine protein phosphatases in apoptosis. Current Opinion in Pharmacology, 2(4), 458-462.
6. Cohen, P. T. (2002). Protein phosphatase 1-targeted in many directions. Journal of Cell Science, 115(Pt 2), 241-256.
7. Cohen, P. (1989). The structure and regulation of protein phosphatases. Annual Review of Biochemistry, 58, 453-508.
8. Cohen, P. T. (1997). Novel protein serine/threonine phosphatases: Variety is the spice of life. Trends in Biochemical Sciences, 22(7), 245-251.
9. Cohen, P. T. W., Brewis, N. D., Hughes, V., & Mann, D. J. (1990). Serine/threonine protein phosphatases: An expanding family. FEBS Letters, 268, 355-358.
10. Cohen, P. T. W. (1991). Cloning of protein-serine/threonine phosphatases. Methods in Enzymology, 201, 398-408.
11. Arndt, K. T., Styles, C. A., & Fink, G. R. (1989). A suppressor of HIS4 transcriptional defect encodes a protein with homology to the catalytic subunit of protein phosphatases. Cell, 56, 527-537.
12. Zhuang, Z., Dean, N. M., & Honkanen, R. E. (1998). Serine/threonine protein phosphatase type 5 acts upstream of p53 to regulate the induction of p21WAF1/Cip1 and mediate growth arrest. Journal of Biological Chemistry, 273(20), 12250-12258.
13. Silverstein, A. M., Galigniana, M. D., Chen, M. S., Owens-Grillo, J. K., Chinkers, M., & Pratt, W. B. (1997). Protein phosphatase 5 is a major component of glucocorticoid receptor.hsp90 complexes with properties of an FK506-binding immunophilin. Journal of Biological Chemistry, 272(26), 16224-16230.
14. Skinner, J., Sinclair, C., Romeo, C., Armstrong, D., Charbonneau, H., & Rossie, S. (1997). Purification of a fatty acid-stimulated protein-serine/threonine phosphatase from bovine brain and its identification as a homolog of protein phosphatase 5. Journal of Biological Chemistry, 272, 22464-22471.
15. Huang, X., Cheng, A., & Honkanen, R. E. (1997). Genomic organization of the human PP4 gene encoding a serine/threonine protein phosphatase (PP4) suggest a common ancestry with PP2A. Genomics, 44, 336-343.
16. Bastians, H., & Ponstingl, H. (1996). The novel human protein serine/threonine phosphatase 6 is a functional homologue of budding yeast Sit4p and fission yeast ppe1, which are involved in cell cycle regulation. Journal of Cell Science, 109(Pt 12), 2865-2874.
17. Huang, X., & Honkanen, R. E. (1998). Molecular cloning, expression and characterization of a novel human serine/threonine protein phosphatase, PP7, that is homologous to Drosophila retinal degeneration C gene product (rdgC). Journal of Biological Chemistry, 273(3), 1462-1468.
18. Swingle, M. R., Honkanen, R. E., & Ciszak, E. M. (2004). Structural basis for the catalytic activity of human serine/threonine protein phosphatase-5. Journal of Biological Chemistry, 279(32), 33992-33999.
19. Yang, J., Roe, S. M., Cliff, M. J., Williams, M. A., Ladbury, J. E., Cohen, P. T. W., et al. (2005). Molecular basis for TPR domain-mediated regulation of protein phosphatase 5. The EMBO Journal, 24, 1-10.
20. Honkanen, R. E., Zwiller, J., Daily, S. L., Khatra, B. S., Dukelow, M., & Boynton, A. L. (1991). Identification, purification, and characterization of a novel serine/threonine protein phosphatase from bovine brain. Journal of Biological Chemistry, 266(10), 6614-6619.
21. Becker, W., Kentrup, H., Klumpp, S., Schultz, J. E., & Joost, H. G. (1994). Molecular cloning of a protein serine threonine phosphatase containing a putative regulatory tetratricopeptide repeat domain. Journal of Biological Chemistry, 269, 22586-22592.
22. Chen, M. X., McPartlin, A. E., Brown, L., Chen, Y. H., Barker, H. M., & Cohen, P. T. W. (1994). A novel human serine/threonine phosphatase, which possesses four tetratricopeptide repeat motifs and localizes to the nucleus. The EMBO Journal, 13(18), 4278-4290.
23. Chinkers, M. (1994). Targeting of a distinctive protein-serine phosphatase to the protein kinase-like domain of the atrial natriuretic peptide receptor. Proceedings of the National Academy of Sciences of the United States of America, 91, 11075-11079.
24. Xu, X., Lagercrantz, J., Zickert, P., Bajalica-Lagercrantz, S., & Zetterberg, A. (1996). Chromosomal localization and 5" sequence of the human protein serine/threonine phosphatase 5 gene. Biochemical and Biophysical Research Communications, 218, 514-517.
25. Chen, M. S., Silverstein, A. M., Pratt, W. B., & Chinkers, M. (1996). The tetratricopeptide repeat domain of protein phosphatase 5 mediates binding to glucocorticoid receptor heterocomplexes and acts as a dominant negative mutant. Journal of Biological Chemistry, 271, 32315-32320.
26. Davies, T. H., Ning, Y. M., & Sanchez, E. R. (2005). Differential control of glucocorticoid receptor hormone-binding function by tetratricopeptide repeat (TPR) proteins and the immunosuppressive ligand FK506. Biochemistry, 44, 2030-2038.
27. Ollendorff, V., & Donoghue, D. J. (1997). The serine/threonine phosphatase PP5 interacts with CDC16 and CDC27, two tetratricopeptide repeat-containing subunits of the anaphase-promoting complex. Journal of Biological Chemistry, 272(51), 32011-32018.
28. Zhao, S., & Sancar, A. (1997). Human blue-light photoreceptor hCRY2 specifically interacts with protein serine/threonine phosphatase 5 and modulates its activity. Photochemistry and Photobiology, 66, 727-731.
29. Shao, J., Hartson, S. D., & Matts, R. L. (2002). Evidence that protein phosphatase 5 functions to negatively modulate the maturation of the Hsp90-dependent heme-regulated eIF2alpha kinase. Biochemistry, 41, 6770-6779.
30. Morita, K., Saitoh, M., Tobiume, K., Matsuura, H., Enomoto, S., Nishitoh, H., et al. (2001). Negative feedback regulation of ASK1 by protein phosphatase 5 (PP5) in response to oxidative stress. The EMBO Journal, 20, 6028-6036.
31. Wechsler, T., Chen, B. P., Harper, R., Morotomi-Yano, K., Huang, B. C., Meek, K., et al. (2004). DNA-PKcs function regulated specifically by protein phosphatase 5. Proceedings of the National Academy of Sciences of the United States of America, 101, 1247-1252.
32. Ali, A., Zhang, J., Bao, S., Liu, I., Otterness, D., Dean, N. M., et al. (2004). Requirement of protein phosphatase 5 in DNA-damage-induced ATM activation. Genes and Development, 18, 249-254.
33. Zhang, J., Bao, S., Furumai, R., Kucera, K. S., Ali, A., Dean, N. M. et al. (2005). Protein phosphatase 5 is required for ATR-mediated checkpoint activation. Molecular and Cellular Biology, 25(22), 9910-9919.
34. Lubert, E. J., Hong, Y., & Sarge, K. D. (2001). Interaction between protein phosphatase 5 and the A subunit of protein phosphatase 2A: Evidence for a heterotrimeric form of protein phosphatase 5. Journal of Biological Chemistry, 276(42), 38582-38587.
35. Yamaguchi, Y., Katoh, H., Mori, K., & Negishi, M. (2002). Galpha(12) and Galpha(13) interact with Ser/Thr protein phosphatase type 5 and stimulate its phosphatase activity. Current Biology, 12, 1353.
36. Gentile, S., Darden, T., Erxleben, C., Romeo, C., Russo, A., Martin, N., et al. (2006). Rac GTPase signaling through the PP5 protein phosphatase. Proceedings of the National Academy of Sciences of the United States of America, 103, 5202-5206.
37. von Kriegsheim, A., Pitt, A., Grindlay, G. J., Kolch, W., & Dhillon, A. S. (2006). Regulation of the Raf-MEK- ERK pathway by protein phosphatase 5. Nature Cell Biology, 8(9), 1011-1016.
38. Richter, K., & Buchner, J. (2001). Hsp90: Chaperoning signal transduction. Journal of Cellular Physiology, 188(3), 281-290.
39. Pratt, W. B., & Toft, D. O. (1997). Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocrine Reviews, 18, 306-360.
40. Frydman, J., & Höhfeld, J. (1997). Chaperones get in touch: The Hip-Hop connection. Trends in Biochemical Sciences, 22, 87-92.
41. Zuo, Z., Urban, G., Scammell, J. G., Dean, N. M., McLean, T. K., Aragon, I. V., et al. (1999). Ser/thr protein phosphatase type 5 (PP5) is a negative regulator of glucocorticoid receptor-mediated growth arrest. Biochemistry, 38(28), 8849-8857.
42. Dean, D. A., Urban, G., Aragon, I. V., Swingle, M., Miller, B., Rusconi, S., et al. (2001). Serine/threonine phosphatase 5 (PP5) participates in the regulation of glucocorticoid receptor nucleocytoplasmic shuttling. BMC Cell Biology, 2(6), 1471-2121.
43. Riggs, D. L., Roberts, P. J., Chirillo, S. C., Cheung-Flynn, J., Prapapanich, V., Ratajczak, T., et al. (2003). The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo. The EMBO Journal, 22, 1158-1167.
44. Denny, W. B., Valentine, D. L., Reynolds, P. D., Smith, D. F., & Scammell, J. G. (2000). Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology, 141, 4107-4113.
45. Davies, T. H., Ning, Y. M., & Sanchez, E. R. (2002). A new first step in activation of steroid receptors: Hormone-induced switching of FKBP51 and FKBP52 immunophilins. Journal of Biological Chemistry, 277, 4597-4600.
46. Wang, Z., Chen, W., Kono, E., Dang, T., & Garabedian, M. J. (2007). Modulation of glucocorticoid receptor phosphorylation and transcriptional activity by C-terminal-associated protein phosphatase. Molecular Endocrinology, 21, 625-634.
47. Conde, R., Xavier, J., McLoughlin, C., Chinkers, M., & Ovsenek, N. (2005). Protein phosphatase 5 is a negative modulator of heat shock factor 1. Journal of Biological Chemistry, 280, 28989-28996.
48. Sumanasekera, W. K., Tien, E. S., Davis, J. W., II, Turpey, R., Perdew, G. H., & Vanden Heuvel, J. P. (2003). Heat shock protein-90 (Hsp90) acts as a repressor of peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARbeta activity. Biochemistry, 42(36), 10726-10735.
49. Meyer, B. K., Petrulis, J. R., & Perdew, J. H. (2000). Aryl hydrocarbon (Ah) receptor levels are selectively modulated by hsp90-associated immunophilin homolog XAP2. Cell Stress Chaperones, 5(3), 243-254.
50. Zuo, Z., Dean, N. M., & Honkanen, R. E. (1998). Serine/threonine protein phosphatase type 5 acts upstream of p53 to regulate the induction of p21WAF1/Cip1 and mediate growth arrest. Journal of Biological Chemistry, 273, 12250-12258.
51. Urban, G., Golden, T., Aragon, I. V., Cowsert, L., Cooper, S. R., Dean, N. M., et al. (2003). Identification of a functional link for the p53-tumor suppressor protein in dexamethasone induced growth suppression. Journal of Biological Chemistry, 278(11), 9747-9753.
52. Sherr, C. J. (1996). Cancer cell cycles. Science, 274, 1672-1677.
53. Zhang, Y., & Xiong, Y. (2001). A p53 Amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation. Science, 292, 1910-1915.
54. Bean, L. J., & Stark, G. R. (2001). Phosphorylation of serines 15 and 37 is necessary for efficient accumulation of p53 following irradiation with UV. Oncogene, 20, 1076-1084.
55. Storey, N. M., O'Bryan, J. P., & Armstrong, D. L. (2002). Rac and Rho mediate opposing hormonal regulation of the ether-a-go-go-related potassium channel. Current Biology, 12, 27-33.
56. Dougherty, M., Müller, J., Ritt, D., Zhou, M., Zhou, X., Copeland, T., et al. (2005). Regulation of Raf-1 by direct feedback phosphorylation. Molecular Cell, 17, 215-224.
57. Urban, G., Golden, T., Aragon, I. V., Scammell, J. G., Dean, N. M., & Honkanen, R. E. (2001). Identification of an Estrogen-inducible Phosphatase (PP5) that converts MCF-7 Human Breast Carcinoma Cells into an Estrogen-Independent phenotype when expressed constitutively. Journal of Biological Chemistry, 276(29), 27638-27646.
58. Ikeda, k., Ogawa, S., Tsukui, T., Horie-Inoue, K., Ouchi, Y., Kato, S., et al. (2004). Protein phosphatase 5 is a negative regulator of estrogen receptor-mediated transcription. Molecular Endocrinology, 18, 1131-1143.
59. Golden, T., Aragon, I. V., Zhou, G., Cooper, S. R., Dean, N. M., & Honkanen, R. E. (2004). Constitutive over expression of serine/threonine protein phosphatase 5 (PP5) augments estrogen-dependent tumor growth in mice. Cancer Letters, 215, 95-100.
60. Zhou, G., Golden, T., Aragon, I. V., & Honkanen, R. E. (2004). Ser/thr protein phosphatase 5 (PP5) inactivates hypoxia-induced activation of an ASK-1/MKK-4/JNK-signaling cascade. Journal of Biological Chemistry, 279, 46595-46605.
61. Nagai, H., Noguchi, T., Takeda, K., & Ichijo, H. (2007). Pathophysiological roles of ASK1-MAP kinase signaling pathways. Biochemistry and Molecular Biology, 40, 1-6.
62. Matsuzawa, A., Nishitoh, H., Tobiume, K., Takeda, K., & Ichijo, H. (2002). Physiological roles of ASK1-mediated signal transduction in oxidative stress- and endoplasmic reticulum stress-induced apoptosis: Advanced findings from ASK1 knockout mice. Antioxidants and Redox Signalling, 4, 415-425.
63. Huang, S., Shu, L., Easton, J., Harwood, F. C., Germain, G. S., Ichijo, H., et al. (2004). Inhibition of mammalian target of rapamycin activates apoptosis signal-regulating kinase 1 signaling by suppressing protein phosphatase 5 activity. Journal of Biological Chemistry, 279, 36490-36496.
64. DiBiase, S. J., Zeng, Z.-C., Chen, R., Hyslop, T., Curran, W. J., Jr., & Iliakis, G. (2000). DNA-dependent protein kinase stimulates an independently active, nonhomologous, end-joining apparatus. Canadian Research, 60, 1245-1253.
65. Abraham, R. T. (2001). Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes and Development, 15, 2177-2196.
66. Yong, W., Bao, S., Chen, H., Dapei, L., Sanchez, E. R., & Shou, W. (2007). Mice lacking protein phosphatase5 are defective in ataxia telangiectasia mutated (ATM)-mediated cell cycle arrest. Journal of Biological Chemistry, 282, 14690-14694.
67. Jeong, J.-Y., Johns, J., Sinclair, C., Park, J.-M., & Rossie, S. (2003). Characterization of Saccharomyces cerevisiae protein Ser/Thr phosphatase T1 and comparison to its mammalian homolog PP5. BMC Cell Biology, 4, 3.
68. Shirato, H., Shima, H., Nakagama, H., Fukuda, H., Watanabe, Y., Ogawa, K., et al. (2000). Expression in hepatomas and chromosomal localization of rat protein phosphatase 5 gene. International Journal of Oncology, 17, 909-912.
69. Ghobrial, I. M., McCormick, D. J., Kaufmann, S. H., Leontovich, A. A., Loegering, D. A., Dai, N. T. et al. (2005). Proteomic analysis of mantle-cell lymphoma by protein microarray. Blood, 105, 3722-3730.
70. Atiye, J., Wolf, M., Kaur, S., Monni, O., Böhling, T., Kivioja, A. et al. (2005). Gene amplifications in osteosarcoma-CGH microarray analysis. Genes Chromosomes Cancer, 42(2), 158-163.
71. Mitelman, F., Johansson, B., Mertens, F. (Eds.) (2007). Mitelman database of chromosome aberrations in cancer. http://cgap.nci.nih.gov/Chromosomes/ Mitelman
72. Lad, C., Williams, N. H., & Wolfenden, R. (2003). The rate of hydrolysis of phosphomonoester dianions and the exceptional catalytic proficiencies of protein and inositol phosphatases. Proceedings of the National Academy of Sciences of the United States of America, 100, 5607-5610.
73. Maynes, J. T., Bateman, K. S., Cherney, M. M., Das, A. K., Luu, H. A., Holmes, C. F., & James, M. N. (2001). Crystal structure of the tumor-promoter okadaic acid bound to protein phosphatase-1. Journal of Biological Chemistry, 276, 44078-44082.
74. Griffith, J. P., Kim, J. L., Kim, E. E., Sintchak, M. D., Thomson, J. A., Fitzgibbon, M. J., et al. (1995). X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP12-FK506 complex. Cell, 82, 507-522.
75. Xing, Y., Xu, Y., Chen, Y., Jeffrey, P. D., Chao, Y., Lin, Z., Li, Z., Strack, S., Stock, J. B., & Shi, Y. (2006). Structure of protein phosphatase 2A core enzyme bound to tumor-inducing toxins. Cell, 127, 341-353.